CD4-Directed Peptide Vaccination Augments an Antitumor Response, but Efficacy Is Limited by the Number of CD8+ T Cell Precursors

Holly L. Hanson, Silvia S. Kang, Lyse A. Norian, Ken Matsui, Leigh A. O'Mara, Paul M. Allen

Research output: Contribution to journalArticle

22 Scopus citations

Fingerprint Dive into the research topics of 'CD4-Directed Peptide Vaccination Augments an Antitumor Response, but Efficacy Is Limited by the Number of CD8<sup>+</sup> T Cell Precursors'. Together they form a unique fingerprint.

Medicine & Life Sciences